Frances Borg
- Rheumatology top 1%
- Otitis Media and Relapsing Polychondritis 8
- Urticaria and Related Conditions 2
- Systemic Lupus Erythematosus Research 2
- Genetics top 5%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 8
-
- Vasculitis and related conditions 13
- Nephrology top 5%
- Ophthalmology top 5%
-
- Autoimmune Bullous Skin Diseases 2
- Systemic Sclerosis and Related Diseases 2
-
- Atherosclerosis and Cardiovascular Diseases 1
Frances Borg
16 papers receiving 958 citations
Peers
Comparison fields: 5 of 53
- Rheumatology 678
- Genetics 318
- Pulmonary and Respiratory Medicine 814
- Nephrology 101
- Ophthalmology 96
Countries citing papers authored by Frances Borg
This map shows the geographic impact of Frances Borg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frances Borg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frances Borg more than expected).
Fields of papers citing papers by Frances Borg
This network shows the impact of papers produced by Frances Borg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frances Borg. The network helps show where Frances Borg may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Frances Borg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2020 | 77 | |
| 3 | 2020 | 1 | |
| 4 | 2020 | 22 | |
| 5 | 2016 | 27 | |
| 6 | Fast track pathway reduces sight loss in giant cell arteritis: results of a longitudinal observational cohort study. | 2015 | 123 |
| 7 | 2015 | 0 | |
| 8 | 2014 | 2 | |
| 9 | 2014 | 4 | |
| 10 | 2012 | 80 | |
| 11 | 2010 | 17 | |
| 12 | 2010 | 42 | |
| 13 | 2010 | 302 | |
| 14 | 2009 | 168 | |
| 15 | 2009 | 36 | |
| 16 | 2008 | 20 | |
| 17 | 2006 | 66 |
About Frances Borg
Frances Borg is a scholar working on Rheumatology, Genetics, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Nephrology, having authored 17 papers that have together received 988 indexed citations. Recurring topics across this work include Vasculitis and related conditions (13 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers), Otitis Media and Relapsing Polychondritis (8 papers), Autoimmune Bullous Skin Diseases (2 papers), Urticaria and Related Conditions (2 papers), Systemic Lupus Erythematosus Research (2 papers), Systemic Sclerosis and Related Diseases (2 papers) and Atherosclerosis and Cardiovascular Diseases (1 paper). The work is most often cited by research in Rheumatology (678 citations), Genetics (318 citations), Pulmonary and Respiratory Medicine (814 citations), Nephrology (101 citations) and Ophthalmology (96 citations). Frances Borg has collaborated with scholars based in United Kingdom, Austria and Netherlands. Frequent co-authors include Bhaskar Dasgupta, J C Nott, Brian P. Bourke, V Kyle, David Isenberg, Michael Power, A. Samanta, Kevin Barraclough, J Hollywood and N. Hassan. Their work appears in journals such as Lara D. Veeken, Annals of the Rheumatic Diseases, Scientific Reports, Best Practice & Research Clinical Rheumatology and Current Allergy and Asthma Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.